MARKET

VAXX

VAXX

Vaxxinity, Inc.
EXMKT
0.0001
NaN%
Closed 09:30 02/13 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
0.0001
MARKET CAP
12.68K
P/E (TTM)
-0.0002
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VAXX last week (0202-0206)?
Weekly Report · 5d ago
Weekly Report: what happened at VAXX last week (0126-0130)?
Weekly Report · 02/02 09:26
Weekly Report: what happened at VAXX last week (0119-0123)?
Weekly Report · 01/26 09:26
Weekly Report: what happened at VAXX last week (0112-0116)?
Weekly Report · 01/19 09:29
Weekly Report: what happened at VAXX last week (0105-0109)?
Weekly Report · 01/12 09:28
Weekly Report: what happened at VAXX last week (1229-0102)?
Weekly Report · 01/05 09:27
Weekly Report: what happened at VAXX last week (1222-1226)?
Weekly Report · 12/29/2025 09:26
Weekly Report: what happened at VAXX last week (1215-1219)?
Weekly Report · 12/22/2025 09:26
More
About VAXX
Vaxxinity, Inc. is a biotechnology company. The Company is engaged in the development of rationally designed prophylactic and therapeutic vaccines to combat common chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its synthetic peptide-based Active Immunotherapy Medicines Platform (AIM Platform, formerly called the Vaxxine Platform) has the potential to enable a new class of medicines. Its pipeline consists of five lead programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications. Its pipeline includes UB-311, UB-312, VXX-301, VXX-401 and UB-313. It also has developed an infectious disease product candidate, UB-612, as a heterologous booster against COVID-19. Its UB-311, which targets the primary pathological process of Alzheimer’s disease (AD) and UB-312, which targets the pathological process of Parkinson’s disease (PD) and other so-called synucleinopathies.

Webull offers Vaxxinity Inc stock information, including EXMKT: VAXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VAXX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VAXX stock methods without spending real money on the virtual paper trading platform.